Rimonabant, a CB1 receptor blocker, causes weight loss and improves insulin sensitivity but is associated with an increased risk of suicide. — Whalespan
Rimonabant, a CB1 receptor blocker, causes weight loss and improves insulin sensitivity but is associated with an increased risk of suicide.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“there's a drug that blocks these cannaboid receptors specifically the cannaboid receptor one CB1 in the brain called Ramona band and Ramon band may still be legal in Europe it's not legal in the States but the trials in the states clearly show that when you give people this drug that blocks CB1 in the brain they lose weight they become more insulin sensitive they also commit suicide”